Quick Facts
- Location: Qianhai Cooperation Zone, Shenzhen, Guangdong Province
- Designation: Shenzhen-Hong Kong Modern Service Industry Cooperation Zone; GBA healthcare integration pilot
- Key Institutions: Shenzhen Qianhai Taikang International Hospital (Cedars-Sinai partnership), HKU-Shenzhen Hospital, Shenzhen People's Hospital
- Best For: Patients seeking access to Hong Kong/Macao-approved drugs not yet available in mainland China, international-standard hospital management, and cross-border healthcare services.
- Special Policies: GBA Drug & Device Measure (early access to HK/Macao medications), 15% income tax for international talent, cross-border insurance settlement, HK/Macao professional qualification recognition.
- Getting There: 20 minutes from Shenzhen Bao'an International Airport; 15 minutes by high-speed rail from Hong Kong West Kowloon.
Introduction
The Shenzhen Qianhai Health Innovation Zone represents a new model of healthcare that is possible only in the Greater Bay Area (GBA) — the mega-region linking mainland China's Guangdong Province with Hong Kong and Macao. Under a groundbreaking framework called the "Hong Kong and Macao Drug and Device Measure" (港澳药械通), designated hospitals in Qianhai can use medications and medical devices that are already approved in Hong Kong or Macao but have not yet been registered in mainland China.
This is a game-changer for international patients. Many globally standard drugs and devices — particularly newer biologics, immunotherapies, and specialized medical equipment — may be available in Hong Kong but not yet approved through China's NMPA process. Through Qianhai's designated hospitals, patients can access these treatments on the mainland, at Chinese prices, without traveling to Hong Kong.
Combined with Hong Kong-style hospital management standards, cross-border insurance settlement, and Shenzhen's position as one of China's most modern and international cities, Qianhai is rapidly emerging as a top medical tourism destination — especially for patients from Southeast Asia, the Middle East, and Africa who are seeking Western pharmaceutical standards at Asian prices.
The GBA Drug & Device Measure Explained
The most important policy for international patients at Qianhai is the GBA Drug & Device Measure. Here's how it works:
What It Means
Hospitals designated under this measure can import and administer drugs and medical devices that are:
- Already approved by Hong Kong's Pharmacy and Poisons Board, or
- Already approved by Macao's Health Bureau, or
- Already approved by major international regulators (FDA, EMA, PMDA) via Hong Kong/Macao recognition
What This Covers
- New biologics and immunotherapies that are approved internationally but awaiting NMPA registration
- Advanced medical devices and diagnostic equipment
- Orphan drugs for rare diseases that may never pursue mainland Chinese approval due to small patient populations
- Latest-generation surgical implants and prosthetics
Practical Impact for Patients
If your doctor at home has recommended a specific drug that is available in Hong Kong but not mainland China, a Qianhai-designated hospital may be able to administer it. This eliminates the need to receive treatment in Hong Kong (where hospital costs are significantly higher) while still accessing the same pharmaceutical standard.
Limitations
- Only applicable at government-designated hospitals within the zone
- Each drug/device requires individual approval for import
- Patient volumes and specific drug availability may vary
Key Institutions
Shenzhen Qianhai Taikang International Hospital
The flagship institution of Qianhai's medical zone, this hospital represents a partnership between Taikang Insurance Group (one of China's largest health insurance conglomerates) and Cedars-Sinai Medical Center (Los Angeles, USA) — one of America's most prestigious academic medical centers.
Key facts:
- Partnership: Cedars-Sinai provides clinical protocols, quality management systems, and cross-training programs. The hospital aims to deliver Cedars-Sinai-level clinical standards at Chinese pricing.
- Specialties: Oncology, cardiovascular medicine, neurosciences, reproductive medicine, regenerative medicine
- Facility: Newly built, designed to international hospital standards with private rooms, advanced imaging suites, and integrated rehabilitation facilities
- Management: Hong Kong-style audit and clinical governance systems — a departure from typical mainland hospital management
- International patients: Full English-language services, international insurance billing, concierge and travel coordination
Best suited for:
- Patients seeking US/European pharmaceutical standards at Chinese costs
- Patients who want a hospital environment and management style familiar to Western healthcare
- Patients requiring drugs approved in Hong Kong but not yet in mainland China
- Priority on oncology, cardiology, and neurosciences
HKU-Shenzhen Hospital
The University of Hong Kong-Shenzhen Hospital is directly operated by Hong Kong's oldest university. It brings Hong Kong's medical management philosophy — transparency, patient-centered care, and international training — to mainland China.
Key facts:
- Affiliation: University of Hong Kong, Faculty of Medicine
- Management: Hong Kong-style appointment system, transparent pricing, no red-envelope culture
- Specialties: General medicine, surgery, gynecology and obstetrics, pediatrics, rehabilitation
- Staff: Mix of Hong Kong-trained and mainland physicians, many with overseas training
- Distinctive feature: Operates on the Hong Kong public hospital model — pre-set consultation fees, standardized treatment charges, and clear billing
Shenzhen People's Hospital
A major comprehensive Grade III-A hospital in Shenzhen with strong surgical and diagnostic departments. While not exclusively part of the Qianhai zone, it participates in GBA healthcare integration and accepts referrals from the zone's specialized facilities.
Key facts:
- Grade: III-A (highest tier)
- Strengths: Gastroenterology, respiratory medicine, urology, cardiac surgery
- International services: English-language coordinators available
- Technology: Advanced robotic surgery (Da Vinci), interventional radiology, nuclear medicine
Special Zone Policies Beyond Drug Access
Professional Qualification Recognition
Hong Kong and Macao-licensed physicians, nurses, and pharmacists can practice at Qianhai-designated hospitals under a mutual recognition framework. This means your treating physician may hold a Hong Kong medical license and training credentials.
15% Individual Income Tax Rate
International medical talent working in Qianhai benefits from a preferential 15% income tax rate (compared to the standard progressive rate of up to 45%). This policy helps attract top international physicians to the zone.
Cross-Border Insurance Settlement
Qianhai is piloting cross-border medical insurance settlement, meaning patients with Hong Kong or Macao insurance may be able to bill directly to their home insurers for treatment received at designated hospitals — a significant convenience for GBA residents.
Hong Kong-Style Medical Audit Standards
Designated hospitals operate under clinical governance standards aligned with Hong Kong's Hospital Authority — including incident reporting, clinical audit, and mortality review — providing an additional layer of quality assurance.
Cost Comparison
| Treatment | Qianhai (USD) | Hong Kong (USD) | USA (USD) | Savings vs HK | Savings vs USA |
|---|---|---|---|---|---|
| Oncology consultation + genomic profiling | $500-$1,500 | $2,000-$5,000 | $3,000-$8,000 | 65-70% | 80% |
| HK-approved immunotherapy (per cycle) | $3,000-$8,000 | $8,000-$15,000 | $15,000-$30,000 | 50-60% | 75% |
| Cardiac stenting procedure | $5,000-$12,000 | $15,000-$30,000 | $25,000-$50,000 | 55-65% | 70-75% |
| Joint replacement (robotic) | $10,000-$18,000 | $25,000-$40,000 | $40,000-$60,000 | 55% | 65-70% |
| Comprehensive health screening | $500-$1,500 | $2,000-$4,000 | $3,000-$6,000 | 60-70% | 75% |
A key advantage: patients can access the same drugs available in Hong Kong at mainland Chinese prices.
Patient Journey at Qianhai
Step 1: Pre-Arrival Assessment
Submit medical records and specify any particular medications you need that may require GBA Drug Measure import. The hospital will verify availability and begin the import process if needed (this may take 2-4 weeks for drugs not already stocked).
Step 2: Convenient Travel
Shenzhen is extremely accessible:
- From Hong Kong: 15 minutes by high-speed rail from West Kowloon
- From international destinations: Direct flights to Shenzhen Bao'an International Airport from major Asian and Middle Eastern hubs
- GBA connectivity: Guangzhou (30 min by train), Zhuhai/Macao (1 hour)
Step 3: Treatment
Expect a hospital experience modeled on international standards — private rooms, transparent billing, English-speaking staff, and clinical protocols aligned with Hong Kong practices.
Step 4: Follow-up
Coordination with your home physician for ongoing treatment. If continuing with a GBA-approved drug, the hospital may arrange multi-cycle supply or facilitate transfer to a Hong Kong pharmacy for ongoing prescriptions.
Living in Qianhai/Shenzhen
Shenzhen is one of China's most modern, livable cities:
- Accommodation: International hotels from $80-$300/night; serviced apartments available for longer stays
- Language: English proficiency is relatively high in Shenzhen, especially in the Qianhai and Nanshan districts
- Dining: Extensive international food scene — Western, Japanese, Korean, Southeast Asian, and Chinese regional cuisines
- Climate: Subtropical; warm year-round; mild winters (ideal for recovery)
- Day trips: Hong Kong (15 min by train), Macao (ferry or bus), beaches along Shenzhen's east coast
Frequently Asked Questions
Q: Can I get any drug approved in Hong Kong at Qianhai hospitals? A: Not automatically. Each drug must be individually approved for import under the GBA Drug Measure. Common internationally-recognized drugs are most likely to be available. Contact the hospital to verify specific drug availability.
Q: How does Qianhai compare to Hong Kong for treatment? A: Qianhai offers access to many of the same drugs and clinical standards as Hong Kong, but at mainland Chinese prices (typically 50-70% lower). Hong Kong may still be preferred for extremely specialized procedures or if you have Hong Kong insurance that doesn't cover mainland treatment.
Q: Is Taikang Hospital actually affiliated with Cedars-Sinai? A: Yes, it's a strategic partnership where Cedars-Sinai provides clinical protocols, quality standards, and staff training. It is not a branch campus of Cedars-Sinai, but it aims to replicate their clinical standards.
Q: Do I need a visa to visit Qianhai? A: Yes — unless you're transiting from Hong Kong under the 144-hour visa-free transit. For treatment stays, apply for a medical visa. The hospital will provide supporting documentation.
Q: Is Qianhai suitable for emergency care? A: For planned, non-emergency treatment, yes. For acute emergencies, Shenzhen People's Hospital and other city hospitals are better equipped with full emergency departments.
How to Get Started
- Check drug availability — If you need a specific medication, confirm with the hospital that it can be imported under the GBA Drug Measure.
- Contact the international department — Provide medical records, specify treatment goals, and ask about drug availability and pricing.
- Plan your travel — Consider combining with Hong Kong for a multi-city medical itinerary if needed.
- Verify insurance — If you have Hong Kong or international insurance, ask about direct billing arrangements.
- Allow preparation time — Drug imports under the GBA Measure may require 2-4 weeks advance notification.
Medical Disclaimer
This article provides general information about the Shenzhen Qianhai Health Innovation Zone and should not be considered medical advice. Drug availability under the GBA Drug & Device Measure is subject to regulatory approval and may change. Treatment costs are estimates. Always consult qualified medical professionals before making treatment decisions. Policy details are subject to government updates.